300583.SZ Stock Analysis
30
Avoid
Based on Eyestock quantitative analysis, 300583.SZ`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly overvalued
Shandong Sito Bio-technology Co., Ltd. provides steroidal pharmaceutical raw materials using biotechnology. The company is headquartered in Heze, Shandong and currently employs 1,140 full-time employees. The company went IPO on 2017-01-06. The firm operates three product segments. The Steroid Raw Materials segment is engaged in the manufacturing of steroid raw materials using genetic engineering technology and microbial transformation technology, such as androstenedione, androstenedione, 9-hydroxyandrostenedione, hydroxyprogesterone and so on. The firm also operates Steroidal Finished Drug segment and Non-Steroidal Finished Drug segment through its subsidiary.